CompanyGraph
Swedish Orphan Biovitrum AB
SOBI · Nasdaq Stockholm · Sweden
Price data from its 0MTD listing on LSE
sobi.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $12.56B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.32: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
119.81BSEK12.56B · vs all stocks (USD)
Trailing P/E
115.82xRevenue (TTM)
30.62BSEK3.21B · vs all stocks (USD)
Profit Margin
4.51%Beta
0.2790xvs all stocks
52-Week Change
64.11%vs all stocks
Market Capitalization
119.81BSEK12.56B · vs all stocks (USD)
Enterprise Value
169.46BSEK17.76B · vs all stocks (USD)
Trailing P/E
115.82xForward P/E
29.20xPEG Ratio
4.76xPrice to Sales (TTM)
5.17xPrice to Book (MRQ)
3.73xEnterprise to Revenue
5.53xEnterprise to EBITDA
13.65xGross Margin
76.68%Profit Margin
4.51%Operating Margin
25.26%Return on Assets (TTM)
7.71%Return on Equity (TTM)
3.40%Revenue (TTM)
30.62BSEK3.21B · vs all stocks (USD)
Revenue per Share (TTM)
88.63SEKUpdated Aug 19, 2026Quarterly Revenue Growth
27.00%Gross Profit (TTM)
24.03BSEK2.52B · vs all stocks (USD)
EBITDA (TTM)
11.71BSEK1.23B · vs all stocks (USD)
Net Income (TTM)
1.38BSEK144.83M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
72.50%Operating Cash Flow (TTM)
7.86BSEK823.73M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.42BSEK357.96M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00SEKUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
6.00MSEKFY2025 · Dec 31, 2025Revenue
28.24BSEKFY2025 · Dec 31, 2025Cost of Goods Sold
6.25BSEKFY2025 · Dec 31, 2025Gross Profit
21.99BSEKFY2025 · Dec 31, 2025Operating Income
922.00MSEK96.63M · vs all stocks (USD)
Pre-tax Income
34.00MSEKFY2025 · Dec 31, 2025Income Tax Expense
-442.00MSEKFY2025 · Dec 31, 2025Net Income
476.00MSEKFY2025 · Dec 31, 2025EBIT
836.00MSEKFY2025 · Dec 31, 2025EBITDA (Income Statement)
10.93BSEKFY2025 · Dec 31, 2025Research & Development
3.32BSEKFY2025 · Dec 31, 2025Selling, General & Administrative
14.29BSEKFY2025 · Dec 31, 2025Other Operating Expenses
45.00MSEKFY2025 · Dec 31, 2025Non-operating Interest Income
22.00MSEKFY2025 · Dec 31, 2025Non-operating Interest Expense
802.00MSEKFY2025 · Dec 31, 2025Minority Interests (P&L)
2.00MSEKFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00SEKFY2025 · Dec 31, 2025Operating Cash Flow
841.00MSEKFY2025 · Dec 31, 2025Free Cash Flow
801.00MSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.04BSEKFY2025 · Dec 31, 2025Starting Profit (CF Statement)
34.00MSEKFY2025 · Dec 31, 2025Stock-based Compensation
250.00MSEKFY2025 · Dec 31, 2025Other Non-cash Items
1.06BSEKFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-884.00MSEKFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
377.00MSEKFY2025 · Dec 31, 2025Capital Expenditures
-40.00MSEKFY2025 · Dec 31, 2025Net Intangibles (CF)
-3.11BSEKFY2025 · Dec 31, 2025Net Acquisitions
-1.00BSEKFY2025 · Dec 31, 2025Purchase of Investments
-41.00MSEKFY2025 · Dec 31, 2025Other Investing Activity
-96.00MSEKFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.18BSEKFY2025 · Dec 31, 2025Long-term Debt Issuance
3.06BSEKFY2025 · Dec 31, 2025Long-term Debt Payments
-7.99BSEKFY2025 · Dec 31, 2025Other Financing Charges
554.00MSEKFY2025 · Dec 31, 2025Net Financing Cash Flow
-4.13BSEKFY2025 · Dec 31, 2025Shares Outstanding
347.29MSharesUpdated Aug 19, 2026Float Shares
223.20MSharesUpdated Aug 19, 2026% Held by Insiders
10.05%vs all stocks
% Held by Institutions
75.03%vs all stocks
Total Cash (MRQ)
1.08BSEK113.39M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.12SEKUpdated Aug 19, 2026Total Debt (MRQ)
17.59BSEK1.84B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4161xCurrent Ratio (MRQ)
0.8750xBook Value per Share (MRQ)
121.69SEKUpdated Aug 19, 2026Total Assets
67.43BSEK7.07B · vs all stocks (USD)
Total Current Assets
14.53BSEKFY2025 · Dec 31, 2025Total Liabilities
29.71BSEKFY2025 · Dec 31, 2025Total Non-current Assets
52.91BSEKFY2025 · Dec 31, 2025Total Non-current Liabilities
13.64BSEKFY2025 · Dec 31, 2025Total Current Liabilities
16.07BSEKFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.04BSEKFY2025 · Dec 31, 2025Accounts Receivable
5.86BSEKFY2025 · Dec 31, 2025Inventory
5.13BSEKFY2025 · Dec 31, 2025Accounts Payable
1.24BSEKFY2025 · Dec 31, 2025Short-term Debt
6.06BSEKFY2025 · Dec 31, 2025Other Current Liabilities
1.35BSEKFY2025 · Dec 31, 2025Long-term Debt
5.44BSEKFY2025 · Dec 31, 2025Other Non-current Liabilities
3.58BSEKFY2025 · Dec 31, 2025Common Stock (Book)
196.00MSEKFY2025 · Dec 31, 2025Retained Earnings
22.40BSEKFY2025 · Dec 31, 2025Total Shareholders' Equity
37.72BSEK3.95B · vs all stocks (USD)
52-Week Low
262.80SEKUpdated Aug 19, 202652-Week High
487.00SEKUpdated Aug 19, 202652-Week Change
64.11%vs all stocks
Beta
0.2790xvs all stocks
50-Day MA
456.45SEKUpdated Aug 19, 2026200-Day MA
397.03SEKUpdated Aug 19, 2026Avg 10-Day Volume
303.78KSharesUpdated Aug 19, 2026Avg 30-Day Volume
420.81KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
3.92SEKUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.77Profit Margin: 0.05
Financial Health
Altman Z-Score 3.32: safe zoneNotable
Altman Z-Score: 3.32
High earnings qualityNotable
Earnings Quality Score: 0.93
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $12.56B, above the global median of $1.15BNotable
Market cap (USD): 12,555,995,956.885Global Median: 1,146,734,693.424
Revenue is $3.21B, above the global median of $520.53MNotable
Revenue (USD): 3,209,185,506.099Global Median: 520,528,949.311
Levered free cash flow is $357.96M, above the global median of $16.24MNotable
Levered free cash flow (USD): 357,957,495.808Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Penumbra Inc.
Tier 1ProductionApproval-Gated PipelineRule
Madrigal Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Elanco Animal Health Incorporated
Tier 1ProductionApproval-Gated PipelineRule
Shanghai United Imaging Healthcare Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Yunnan Baiyao Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cipla Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang NHU Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Axsome Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Haisco Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Recordati Industria Chimica e Farmaceutica S.p.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Haisco Pharmaceutical Group Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Zhejiang Zhongjian Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Shenzhen Click Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth